Source · Prevention of Future Deaths
Susan Gladstone
Ref: 2023-0485
Date: 20 Nov 2023
Coroner: Graham Danbury
Area: Hertfordshire
Responses identified: 0 / 1
View PDF
The report identifies a potential interaction between tramadol and warfarin that caused a dangerously high INR level, and that there was no warning to the prescribing doctor about this possible interaction.
Date
20 Nov 2023
56-day deadline
15 Jan 2024 est.
Responses identified
0 of 1
Coroner's concerns
The report identifies a potential interaction between tramadol and warfarin that caused a dangerously high INR level, and that there was no warning to the prescribing doctor about this possible interaction.
View full coroner's concerns
(1) Mrs Gladstone had been prescribed warfarin for a number of years and her levels were regularly checked by the Anticoagulation Service. On 20th December 2020 Mrs Gladstone was prescribed tramadol for low back pain, with a further prescription on 4th January 2021.
(2) On 21st December 2020 her International Normalised Ratio [INR] was found to be 3.3. When she was admitted to Lister Hospital on 6th January 2021 tests showed her INR to be 11.6. Immediate action to reverse this was taken. The evidence showed that this level of blood thinning was likely to cause significant bleeding including in the brain. The cause of death was bleeding in the brain (3) A comment from the Anticoagulation Service in relation to tramadol reads "Known interactor although this is not listed in the BNF, from experience we have seen that this can increase the INR." There was nothing to warn the prescribing doctor of any possible interaction.(4) I found on the balance of probabilities that an interaction between tramadol and warfarin had caused this dangerous, and in the event fatal, INR level to develop.
(2) On 21st December 2020 her International Normalised Ratio [INR] was found to be 3.3. When she was admitted to Lister Hospital on 6th January 2021 tests showed her INR to be 11.6. Immediate action to reverse this was taken. The evidence showed that this level of blood thinning was likely to cause significant bleeding including in the brain. The cause of death was bleeding in the brain (3) A comment from the Anticoagulation Service in relation to tramadol reads "Known interactor although this is not listed in the BNF, from experience we have seen that this can increase the INR." There was nothing to warn the prescribing doctor of any possible interaction.(4) I found on the balance of probabilities that an interaction between tramadol and warfarin had caused this dangerous, and in the event fatal, INR level to develop.
Report sections
Investigation and inquest
On 11 January 2021 I commenced an investigation into the death of Susan Ann GLADSTONE. The investigation concluded at the end of the inquest on 20 November 2023. The conclusion of the inquest was She died as a result of a generally unknown interaction between warfarin and tramadol which caused exceptional thinning of her blood 1a Intraparenchymal and Subarachnoid Haemorrhage 1b 1c
Similar PFD reports
Related inquiry recommendations
Report details
- Reference
- 2023-0485
- Date of report
- 20 November 2023
- Coroner
- Graham Danbury
- Coroner area
- Hertfordshire
Responses identified
Responses identified
0 of 1
1 response not yet linked
Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 15 Jan 2024 (estimated).
Sent to
- NHS England